Delgado-Sequera Alejandra, Pérez-Revuelta Jose I, Caballero-García Andres, Durán-Ruiz MªCarmen, Romero-Lopez-Alberca Cristina, García-Mompó Clara, González-Saiz Francisco, Rodríguez-Iglesias Manuel, Sanchez-Morillo Daniel, Robledo Patricia, Perez Victor, Berrocoso Esther, Hidalgo-Figueroa Maria
Neuropsychopharmacology and Psychobiology Research Group, University of Cadiz, Cádiz, Spain.
Biomedical Research and Innovation Institute of Cadiz (INiBICA), Cádiz, Spain.
Mol Med. 2024 Dec 23;30(1):271. doi: 10.1186/s10020-024-01039-8.
Bipolar disorder (BD) is a severe, chronic mental illness that remains difficult to diagnose due to the lack of specific biomarkers, relying primarily on clinical assessments. Early diagnosis and treatment are essential for improving prognosis and lowering suicide risk. This study aimed to identify biomarkers and therapeutic targets by utilizing olfactory neuroepithelium (ONE) cells from patients with BD and controls.
Immunofluorescence of ONE cells, along with proteomic and RNA sequencing analyses, was performed to investigate cytoskeletal changes and pathways involved in cell adhesion, movement, and morphology. Additionally, potential biomarkers were investigated in blood samples to improve clinical accessibility.
Thus, according to functional assays, ONE cells derived from BD patients exhibited decreased substrate adhesion, reduced cell migration, and morphological changes compared to control cells. In addition, proteomic and RNAseq analyses in ONE cells and peripheral blood mononuclear cells (PBMCs) revealed alterations in pathways such as RhoA/PAK/Integrin and Actin Cytoskeleton Signaling, as well as significant changes in inflammatory and immunological pathways. AUROC analysis identified proteins like PTK2 as potential diagnostic biomarkers, showing altered expression in both ONE cells and PBMCs. PTK2 RNA expression correlated with distinct morphological traits in BD ONE cells.
In summary, this study identified cytoskeletal alterations, reduced adhesion, and disrupted migration patterns in BD ONE cells, highlighting molecular mechanisms underlying these changes and emphasizing PTK2's role as a potential diagnostic biomarker for BD.
双相情感障碍(BD)是一种严重的慢性精神疾病,由于缺乏特异性生物标志物,主要依靠临床评估,因而难以诊断。早期诊断和治疗对于改善预后及降低自杀风险至关重要。本研究旨在利用双相情感障碍患者和对照者的嗅神经上皮(ONE)细胞来识别生物标志物和治疗靶点。
对ONE细胞进行免疫荧光检测,并结合蛋白质组学和RNA测序分析,以研究细胞骨架变化以及参与细胞黏附、运动和形态形成的信号通路。此外,还对血液样本中的潜在生物标志物进行了研究,以提高临床可及性。
因此,根据功能分析,与对照细胞相比,双相情感障碍患者来源的ONE细胞表现出底物黏附减少、细胞迁移降低和形态变化。此外,对ONE细胞和外周血单个核细胞(PBMC)的蛋白质组学和RNA测序分析揭示了RhoA/PAK/整合素和肌动蛋白细胞骨架信号等信号通路的改变,以及炎症和免疫信号通路的显著变化。受试者工作特征曲线(AUROC)分析确定了PTK2等蛋白质作为潜在的诊断生物标志物,其在ONE细胞和PBMC中均表现出表达改变。PTK2 RNA表达与双相情感障碍ONE细胞的不同形态特征相关。
总之,本研究确定了双相情感障碍ONE细胞中的细胞骨架改变、黏附减少和迁移模式破坏,突出了这些变化背后的分子机制,并强调了PTK2作为双相情感障碍潜在诊断生物标志物的作用。